Bladder cancer Board decisions

The Veteran's bladder cancer is presumed related to his exposure to herbicide agents during service. The Board finds the Veteran exposed to herbicides and grants service connection for this condition. Service connection for lower extremity peripheral neuropathy, right; chronic kidney disease; atrial fibrillation (claimed as AFib); and bilateral hearing loss are remanded due to a duty-to-assist error.

The Board has dismissed the appeals for service connection for bladder cancer and left urethral cancer due to herbicide agent exposure as the appellant withdrew her appeal.

The Veteran's bladder cancer was not found to be related to his military service, including exposure to herbicide agents. The Board denied the claim as there is no evidence of qualifying location or presumed exposure.

The Veteran's service-connected peripheral neuropathy of the bilateral lower extremities and bladder cancer residuals have been granted initial ratings, with a TDIU also being granted.

The Veteran's bladder cancer was rated at 100% from October 18, 2017, to May 1, 2018. From April 12, 2016, to October 18, 2017, and from May 1, 2018, to May 17, 2022, the Veteran was rated at 10%. The effective date for service connection of erectile dysfunction (ED) as secondary to bladder cancer is March 4, 2022.

The Veteran's spinal stenosis is due to his service-connected bladder cancer, and the Board has granted service connection for this condition.

The Board has determined that the Veteran's bladder cancer may be related to his service, but more evidence is needed to establish a direct link. The case is being remanded for further development and an examination.

Service connection for tinnitus, hypertension associated with herbicide agent exposure, and bladder cancer associated with herbicide agent exposure has been granted.,Service connection for recurrent gonorrhea residuals, recurrent anthrax vaccination residuals, and an acquired eye disability (refractive error and hyperopia) has not been granted.

The Board has determined that the Veteran's metastatic urinary bladder cancer, which caused his death, was related to in-service toxic exposure risk activities and is service-connected.

The Veteran's appeal for a rating in excess of 10 percent for residuals of bladder cancer is dismissed because the March 2025 rating decision was a purely ministerial implementation of the March 2025 Board decision.

The Veteran's PTSD is rated at 30% prior to April 30, 2021 and at 50% from that date forward.,For the period from July 11, 2023, to May 1, 2025, the Veteran has a combined disability rating of 100%. The TDIU claim is denied for this period.

The Veteran seeks an earlier effective date for residuals of bladder cancer in remission, urinary tract infection, and hematospemia. The Board finds that the records needed to substantiate this claim have not been obtained and orders them to be obtained.

The Veteran's residuals of bladder cancer are rated at a 40 percent rating from August 31, 2021. The Board found the evidence to be in relative balance as to whether his service-connected residuals caused urinary frequency requiring awakening to void five or more times per night.

The Veteran's bladder cancer is presumed to be related to his in-service exposure to burn pits and other toxins during service in Southwest Asia, and the claim for service connection is granted.

The Veteran's service connection claims for bladder cancer, prostate cancer, abdominal scar secondary to these conditions, ED secondary to prostate cancer, and other specified trauma and stressor related disorder are all granted. The Veteran is also awarded Special Monthly Compensation (SMC) based on loss of use of a creative organ.

The Board has determined that the Veteran's bladder cancer is due to his in-service exposure to benzene and his use of tobacco as a coping mechanism for his service-connected PTSD. Therefore, service connection for bladder cancer is granted.

The Board granted a 40 percent disability rating for bladder cancer in remission with urinary incontinence and denied an increased disability rating in excess of 30 percent for asthma.

The Board granted service connection for bladder cancer, finding it to be related to the Veteran's in-service herbicide exposure.

The Board granted an effective date of December 12, 2023, for a 50 percent evaluation of bipolar disorder and remanded the other issues for further development.

The Board granted service connection for bladder cancer, diabetes mellitus, type 2, and an acquired psychiatric disability (unspecified depressive disorder), but denied a compensable rating for bilateral hearing loss.